Regency Capital Management’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Regency Capital Management’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-510,000	Closed	-$510K	–	71
2025 Q3	$510K	Hold	510,000	–	–	0.24%	49
2025 Q2	$510K	Hold	510,000	–	–	0.27%	49
2025 Q1	$510K	Hold	510,000	–	–	0.3%	35
2024 Q4	$510K	Hold	510,000	–	–	0.28%	40
2024 Q3	$510K	Hold	510,000	–	–	0.28%	35
2024 Q2	$510K	Hold	510,000	–	–	0.33%	37
2024 Q1	$510K	Hold	510,000	–	–	0.32%	40
2023 Q4	$510K	Buy	510,000 +480,000	+1,600%	+$480K	0.34%	40
2023 Q3	$506K	Hold	30,000	–	–	0.43%	36
2023 Q2	$506K	Sell	30,000 -8,000	-21%	-$105K	0.44%	32
2023 Q1	$323K	Buy	+38,000	New	+$313K	0.39%	27

Regency Capital Management's VECT Position: Q4 2025 in Review

Regency Capital Management sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q4 2025, closing a stake of 510,000 shares — an estimated $510K sold.

Regency Capital Management first reported a position in VECT in Q1 2023 and held it in 11 quarters. The position peaked at $510K in Q3 2025. 0 funds tracked by Wall St. Rank hold VECT as of Q4 2025.

Regency Capital Management reported no remaining VectivBio Holding AG Ordinary Shares position as of Q4 2025 after selling out during the quarter.
Regency Capital Management sold 510,000 VectivBio Holding AG Ordinary Shares shares in Q4 2025, an estimated $510K.
Regency Capital Management first reported a position in VectivBio Holding AG Ordinary Shares in Q1 2023 and held it in 11 quarters.
Regency Capital Management's VectivBio Holding AG Ordinary Shares position peaked at $510K in Q3 2025.
0 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q4 2025.

Based on Regency Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.